Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.
Mitsubishi Gas Chemical has partnered with Methanol Reformer and Element 1 Corp. to develop as well as commercialize hydrogen ...
Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results